Sixth Street, Goldman invest in $7b merger of Datavant and Ciox Health

Also involved in financing the deal is an existing investor group led by New Mountain Capital, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation - JJDC, Inc and Flex Capital.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this